SEAN LAVIN JOINS MI-VAD STRATEGIC ADVISORY BOARD.
MI-VAD, Inc. is pleased to announce the appointment of Sean Lavin M.D. to our Strategic Advisory Board. Dr. Lavin will focus on financial advice, strategic alliances, and investor outreach. As a physician with training in surgery, he will also be able to help MI-VAD source ideas on ways to help surgical implanters and patients around the world. Sean enjoys working with early-stage companies. He uses his medical expertise and Wall Street experience to select innovative start-ups that often become very large multinational corporations that provide therapies to patients around the world. Since starting his Wall Street career in 2006, Sean …
CHRIS JENSEN JOINS MI-VAD STRATEGIC ADVISORY BOARD.
MI-VAD, Inc. is pleased to announce the appointment of Chris Jensen to our Strategic Advisory Board. Chris loves the energy, excitement, fun and “yes we can” spirit of start up companies. When the start up phase morphs into rapid growth, commercialisation and starting to change the world then the fun increases. This has translated in founding several high growth Technology companies including Left Technologies (Left.io), RightMesh AG (RightMesh.io) and Left Travel (Left Travel.com). Over the past decade Chris’s companies won many awards including the Deloitte Fast 50 for Canada (#17 and #12) and the Deloitte Fast 500 for North America …
MI-VAD SELECTED AS FINALIST IN PRESTIGIOUS CARDIOVASCULAR INNOVATION COMPETITION
MI-VAD, Inc., a Rochester, Minnesota based company announced it’s selection as a finalist in the prestigious “Innovation in Cardiovascular Interventions” (ICI) 2019 competition in Tel Aviv. MI-VAD presented its innovative ventricular assist device (“VAD”) that aims to transform the treatment of end stage heart failure, increase longevity, alleviate suffering and improve the quality of life for heart failure patients. During the three-day conference, 14 finalist companies presented from more than a hundred entrants. The finalists were chosen by a panel of physicians, medical experts and venture capitalists. Heart failure (HF) is a progressive condition in which the heart’s muscle becomes …
D. BRUCE MACDONALD JOINS MI-VAD STRATEGIC ADVISORY BOARD.
MI-VAD, Inc. is pleased to announce the appointment of D. Bruce Macdonald to our Strategic Advisory Board. Mr. Macdonald joins MIVAD with an extensive background in the financial services industry and brings a deep level of expertise and knowledge in finance, as well as corporate governance. His previous experience includes his role as Head, Wholesale Technology and Operations for RBC’s Capital Markets and Wealth Management businesses. Most recently, Mr. Macdonald was responsible for RBC’s Commodities Trading business. He was also Co-CEO of RBC (Barbados) Trading Bank Corp, where he led RBC’s Discretionary Capital Group in the Bahamas. Mr. Macdonald’s corporate …
VIQ PERVAAZ JOINS MI-VAD STRATEGIC ADVISORY BOARD.
MI-VAD, Inc. is pleased to announce the appointment of Vic Pervaaz to our Strategic Advisory Board. Mr Pervaaz is a Partner with Ernst & Young’s People Advisory group. He is responsible for the Americas Life Sciences strategy and portfolio from a human capital perspective. He has spent a significant part of his career in C-suite leadership capacities in the Pharmaceutical/Consumer Products industry. This has included leadership positions in Product Development/R&D, Innovation, M&A, Global Operations, Marketing, Corporate Affairs, Public Relations, and Organizational Effectiveness. Viq has previously served as Chief Project Officer, providing portfolio/change management and lean/six sigma expertise to enterprise transformation, …
DR. FERAS BADER JOINS MI-VAD TECHNICAL ADVISORY BOARD.
MI-VAD, Inc. is pleased to announce the appointment of Feras Bader MD, of Abu Dhabi, UAE to our Technical Advisory Board. “Over the past 15 years since I specialized in the field of advanced heart failure and transplantation, I have seen many patients die prematurely as their condition progressed despite available medication and device therapies. Although heart transplantation remains the definitive solution in end-stage heart failure, it is severely limited by the shortage of organ donors, leaving the future very promising for advances in artificial heart pumps. While technology continues to flourish in this field, there are still important limitations. With …
DR. LYLE JOYCE JOINS MI-VAD TECHNICAL ADVISORY BOARD.
MI-VAD, Inc. is pleased to announce the appointment of Lyle Joyce MD PhD, of Milwaukee, Wisconsin to our Technical Advisory Board. “Surgeons have wished for a truly intra-cavitary blood pump for years and the thought of a universal pump that can serve either the right or left side (or both) is a dream come true. I am excited to have this opportunity to help bring this design to clinical fruition. It will be a complete game changer for mechanical circulatory support”. Dr. Joyce earned his Doctorate of Medicine from Baylor College of Medicine in 1973, and received his Ph.D. in …
DR. JAMES ANTAKI JOINS MI-VAD TECHNICAL ADVISORY BOARD AS CHAIRMAN.
MI-VAD, Inc. is pleased to announce the appointment of James F. Antaki, PhD, of Ithaca New York as Chairman of our Technical Advisory Board. “I am straining at my leash to apply lessons learned over the past three decades (!) towards this truly superior, disruptive heart-assist solution. I’m exceptionally grateful for the opportunity to contribute to this worthy endeavor – that will improve the quality of patients lives who are suffering from advanced heart failure” Dr. Antaki currently serves as the Lowell and Susan McAdam Professor of Heart Assist Technology, Department of Biomedical Engineering at Cornell University in Ithaca, New …
